Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events

Cancer Genet Cytogenet. 2005 Aug;161(1):74-7. doi: 10.1016/j.cancergencyto.2005.01.008.

Abstract

We describe the cytogenetic, fluorescence in situ hybridization (FISH), and molecular findings in a patient who developed a typical chronic lymphocytic leukemia (CLL) 20 months after the diagnosis of a Philadelphia (Ph)-positive chronic myeloid leukemia. Unstimulated bone marrow culture showed a 46,XX,t(9;22)(q34;q11) karyotype, and interphase FISH detected the presence of a BCR/ABL fusion signal in 13% of cells. On stimulated bone marrow culture, a normal karyotype and a 13q14 deletion by interphase FISH with D13S319 probe in 14% of the cells were found. Molecular studies detected the chimeric BCR/ABL messengers by nested reverse-transcriptase polymerase chain reaction. The B-cellular clone was documented by the presence of a clonal heavy chain immunoglobulin rearrangement. The coexistence of these two hematologic malignancies leads to questions about their cell(s) of origin. We provide evidence that CLL arose in a Ph-negative clone. The implications of these findings are discussed.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • B-Lymphocytes / pathology
  • Cell Lineage
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 22 / genetics
  • Chromosomes, Human, Pair 9 / genetics
  • Female
  • Fusion Proteins, bcr-abl / genetics*
  • Gene Rearrangement
  • Humans
  • Immunoglobulin Heavy Chains
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Neoplasms, Second Primary / genetics*
  • Neoplasms, Second Primary / pathology
  • Philadelphia Chromosome
  • Translocation, Genetic / genetics*
  • Tumor Cells, Cultured

Substances

  • Immunoglobulin Heavy Chains
  • Fusion Proteins, bcr-abl